BioCentury | Jan 6, 2017
Company News

Vectura, Mundipharma deal

...inhaler (pMDI). Mundipharma held the option from Skyepharma plc under a December 2015 deal. Vectura acquired Skyepharma...
BioCentury | Sep 5, 2016
Clinical News

Flutiform fluticasone propionate/formoterol: Phase III data

...Asian trial of Flutiform later this year. Mundipharma, which has European rights to flutiform from SkyePharma plc...
...in 18 European countries to treat asthma in patients ages 12 and older. Vectura acquired SkyePharma...
BioCentury | Aug 30, 2016
Clinical News

Flutiform misses in COPD study

...Tokyo:4569) has Japanese rights. Vectura gained Flutiform through its L441.3 million ($632.2 million) acquisition of SkyePharma plc...
BioCentury | Jun 20, 2016
Company News

Lucideon, Skyepharma deal

...payments, plus single-digit royalties. Lucideon declined to disclose financial terms. Lucideon Ltd. , Staffordshire, U.K. Skyepharma plc...
BioCentury | Apr 14, 2016
Company News

Management tracks

...named David Weiner CMO. He was CMO at aTyr Pharma Inc. (NASDAQ:LIFE). Drug delivery company Skyepharma plc...
BioCentury | Mar 21, 2016
Company News

Skyepharma, Vectura deal

...acquire fellow inhaled respiratory drug company Skyepharma in a deal that the companies say values Skyepharma...
...in a deal that the companies say values Skyepharma at about L441.3 million ($634.2 million). Skyepharma...
...Skyepharma’s close of 393.50p on March 15, the day before the deal was announced. If Skyepharma...
BioCentury | Mar 17, 2016
Company News

Vectura acquiring Skyepharma

...a stock deal that values Skyepharma at about L441.3 million ($634.2 million). The deal combines Skyepharma's...
...company. The boards of both companies backed the deal, which is subject to shareholder approval. Skyepharma...
BioCentury | Jan 11, 2016
Company News

Skyepharma, Mundipharma deal

...following feasibility work, which Skyepharma expects to complete in 2Q16. If Mundipharma exercises its option, Skyepharma...
...provide chemistry, manufacturing and control services to Mundipharma to support development, which Mundipharma would fund. Skyepharma...
...this year. The partners declined to disclose which indications would be pursued with SKP-2076, but Skyepharma...
BioCentury | Feb 16, 2015
Financial News

Skyepharma financial update

...Skyepharma plc (LSE:SKP), London, U.K. Business: Drug delivery Date announced: 2015-02-13 Note: Skyepharma plans to repay...
BioCentury | Jan 5, 2015
Finance

4Q14 Stock Wrap-up: Grow early, grow often

...for BTG plc (LSE:BTG) to £3 billion ($4.7 billion). Two small-caps - drug delivery company SkyePharma plc...
Items per page:
1 - 10 of 644
BioCentury | Jan 6, 2017
Company News

Vectura, Mundipharma deal

...inhaler (pMDI). Mundipharma held the option from Skyepharma plc under a December 2015 deal. Vectura acquired Skyepharma...
BioCentury | Sep 5, 2016
Clinical News

Flutiform fluticasone propionate/formoterol: Phase III data

...Asian trial of Flutiform later this year. Mundipharma, which has European rights to flutiform from SkyePharma plc...
...in 18 European countries to treat asthma in patients ages 12 and older. Vectura acquired SkyePharma...
BioCentury | Aug 30, 2016
Clinical News

Flutiform misses in COPD study

...Tokyo:4569) has Japanese rights. Vectura gained Flutiform through its L441.3 million ($632.2 million) acquisition of SkyePharma plc...
BioCentury | Jun 20, 2016
Company News

Lucideon, Skyepharma deal

...payments, plus single-digit royalties. Lucideon declined to disclose financial terms. Lucideon Ltd. , Staffordshire, U.K. Skyepharma plc...
BioCentury | Apr 14, 2016
Company News

Management tracks

...named David Weiner CMO. He was CMO at aTyr Pharma Inc. (NASDAQ:LIFE). Drug delivery company Skyepharma plc...
BioCentury | Mar 21, 2016
Company News

Skyepharma, Vectura deal

...acquire fellow inhaled respiratory drug company Skyepharma in a deal that the companies say values Skyepharma...
...in a deal that the companies say values Skyepharma at about L441.3 million ($634.2 million). Skyepharma...
...Skyepharma’s close of 393.50p on March 15, the day before the deal was announced. If Skyepharma...
BioCentury | Mar 17, 2016
Company News

Vectura acquiring Skyepharma

...a stock deal that values Skyepharma at about L441.3 million ($634.2 million). The deal combines Skyepharma's...
...company. The boards of both companies backed the deal, which is subject to shareholder approval. Skyepharma...
BioCentury | Jan 11, 2016
Company News

Skyepharma, Mundipharma deal

...following feasibility work, which Skyepharma expects to complete in 2Q16. If Mundipharma exercises its option, Skyepharma...
...provide chemistry, manufacturing and control services to Mundipharma to support development, which Mundipharma would fund. Skyepharma...
...this year. The partners declined to disclose which indications would be pursued with SKP-2076, but Skyepharma...
BioCentury | Feb 16, 2015
Financial News

Skyepharma financial update

...Skyepharma plc (LSE:SKP), London, U.K. Business: Drug delivery Date announced: 2015-02-13 Note: Skyepharma plans to repay...
BioCentury | Jan 5, 2015
Finance

4Q14 Stock Wrap-up: Grow early, grow often

...for BTG plc (LSE:BTG) to £3 billion ($4.7 billion). Two small-caps - drug delivery company SkyePharma plc...
Items per page:
1 - 10 of 644